Bain Capital Specialty Finance (BCSF)
(Delayed Data from NYSE)
$16.44 USD
+0.04 (0.24%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $16.47 +0.03 (0.18%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$16.44 USD
+0.04 (0.24%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $16.47 +0.03 (0.18%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Zacks News
Oracle's (ORCL) Healthcare Expansion to Aid Long-Term Growth
by Zacks Equity Research
Oracle's (ORCL) portfolio of healthcare offerings expands with the latest Oracle Health Insurance Data Exchange Cloud Service, which is expected to aid long-term growth.
Oracle (ORCL) Launches AI Assistant for Healthcare Providers
by Zacks Equity Research
Oracle (ORCL) announces the general availability of its Clinical Digital Assistant, an AI-powered tool designed to improve patient care in ambulatory clinics across the United States.
Does Oracle's (ORCL) Healthcare Roster Suggest Bright Prospects?
by Zacks Equity Research
Oracle's (ORCL) portfolio of offerings and increased adoption in the healthcare sector are expected to aid top-line growth in the near term.
Are Finance Stocks Lagging Bain Capital Specialty Finance (BCSF) This Year?
by Zacks Equity Research
Here is how Bain Capital Specialty (BCSF) and AllianceBernstein (AB) have performed compared to their sector so far this year.
Zacks Industry Outlook Highlights Bain Capital Specialty Finance, Barings BDC and Crescent Capital
by Zacks Equity Research
Bain Capital Specialty Finance, Barings BDC and Crescent Capital have been highlighted in this Industry Outlook article.
3 SBIC & Commercial Finance Stocks to Buy Amid Grim Industry Prospects
by Swayta Shah
Weak asset quality, high rates and macroeconomic woes are likely to hurt Zacks SBIC & Commercial Finance industry players like Bain Capital (BCSF), Barings BDC (BBDC) and Crescent Capital (CCAP). Yet, decent financing demand across sectors is likely to aid.
Bain Capital Specialty (BCSF) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Bain Capital Specialty (BCSF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What's in the Cards for Bain Capital's (BCSF) Q3 Earnings?
by Zacks Equity Research
An increase in total investment income on the back of higher interest rates is expected to have supported Bain Capital's (BCSF) Q3 earnings.
Is Arbor Realty Trust (ABR) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Arbor Realty Trust (ABR) and Bain Capital Specialty (BCSF) have performed compared to their sector so far this year.
Bain Capital Specialty (BCSF) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Bain Capital Specialty (BCSF) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Americold Realty Trust (COLD) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Americold Realty Trust Inc. (COLD) and Bain Capital Specialty (BCSF) have performed compared to their sector so far this year.
Are Finance Stocks Lagging Crescent Capital BDC (CCAP) This Year?
by Zacks Equity Research
Here is how Crescent Capital BDC (CCAP) and Bain Capital Specialty (BCSF) have performed compared to their sector so far this year.
Is Brookfield Infrastructure Partners (BIP) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Brookfield Infrastructure Partners (BIP) and Bain Capital Specialty (BCSF) have performed compared to their sector so far this year.
Are Finance Stocks Lagging Brookfield Infrastructure Partners (BIP) This Year?
by Zacks Equity Research
Here is how Brookfield Infrastructure Partners (BIP) and Bain Capital Specialty (BCSF) have performed compared to their sector so far this year.
Bain Capital Specialty (BCSF) Q4 Earnings Meet Estimates
by Zacks Equity Research
Bain Capital Specialty (BCSF) delivered earnings and revenue surprises of 0% and 7.59%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights: Main Street Capital, Bain Capital Specialty Finance and Newtek Business Services
by Zacks Equity Research
Zacks Industry Outlook Highlights: Main Street Capital, Bain Capital Specialty Finance and Newtek Business Services
3 SBIC & Commercial Finance Stocks to Buy Despite Low Rates
by Swayta Shah
While lower rates and pre-payments hurt the Zacks SBIC & commercial finance industry players, robust economic growth, impressive asset quality, and regulatory changes will keep aiding Main Street Capital (GBDC), Bain Capital (BCSF), and Newtek (NEWT).
Bain Capital Specialty (BCSF) Q3 Earnings Match Estimates
by Zacks Equity Research
Bain Capital Specialty (BCSF) delivered earnings and revenue surprises of 0.00% and 9.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Bain Capital Specialty (BCSF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Bain Capital Specialty (BCSF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bain Capital Specialty (BCSF) Q2 Earnings Match Estimates
by Zacks Equity Research
Bain Capital Specialty (BCSF) delivered earnings and revenue surprises of 0.00% and 1.04%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights: Golub Capital BDC, Bain Capital Specialty Finance and Newtek Business Services Corp
by Zacks Equity Research
Zacks Industry Outlook Highlights: Golub Capital BDC, Bain Capital Specialty Finance and Newtek Business Services Corp
3 SBIC & Commercial Finance Stocks to Buy Amid Challenges
by Swayta Shah
While lower rates and pre-payments hurt the Zacks SBIC & commercial finance industry players, robust economic growth, impressive asset quality and regulatory changes are likely to aid Golub Capital (GBDC), Bain Capital (BCSF) and Newtek (NEWT).
3 SBIC & Commercial Finance Stocks to Buy Amid Challenges
by Swayta Shah
While lower rates and pre-payments hurt the Zacks SBIC & commercial finance industry players, robust economic growth, impressive asset quality and regulatory changes are likely to aid Golub Capital (GBDC), Bain Capital (BCSF) and Newtek (NEWT).
Gladstone (GAIN) Announces Sale of Head Country Portfolio
by Zacks Equity Research
Gladstone (GAIN) announces sale of portfolio company, Head Country, in turn generating meaningful realized profits on the investment made.
Earnings Preview: Bain Capital Specialty (BCSF) Q4 Earnings Expected to Decline
by Zacks Equity Research
Bain Capital Specialty (BCSF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.